The impact of experimental preconditioning using vascular endothelial growth factor in stroke and subarachnoid hemorrhage
- PMID: 23634319
- PMCID: PMC3619542
- DOI: 10.1155/2013/948783
The impact of experimental preconditioning using vascular endothelial growth factor in stroke and subarachnoid hemorrhage
Abstract
Vascular endothelial growth factor (VEGF) stimulating angiogenesis was shown to be a potential novel therapeutic approach for the treatment of ischemic vascular diseases. The goal of the present study was to examine whether transfection of VEGF before occurrence of major stroke (part I) and cerebral vasospasm after experimental subarachnoid hemorrhage (SAH; part II) develops neuroprotective qualities. A total of 25 (part I) and 26 (part II) brains were analyzed, respectively. In part one, a significant reduction of infarct volume in the VEGF-treated stroke animals (43% reduction, P < 0.05) could be detected. In part two, significant vasospasm was induced in all hemorrhage groups (P < 0.02). Analyzing microperfusion, a significant higher amount of perfused vessels could be detected (P < 0.01), whereas no significant effect could be detected towards macroperfusion. Histologically, no infarctions were observed in the VEGF-treated SAH group and the sham-operated group. Minor infarction in terms of vasospasm-induced small lesions could be detected in the control vector transduced group (P = 0.05) and saline-treated group (P = 0.09). The present study demonstrates the preconditioning impact of systemic intramuscular VEGF injection in animals after major stroke and induced severe vasospasm after SAH.
Figures




Similar articles
-
Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.Neurosurgery. 2002 Nov;51(5):1128-34; discussion 1134-5. doi: 10.1097/00006123-200211000-00005. Neurosurgery. 2002. PMID: 12383357
-
Cerebral angiogenesis and expression of VEGF after subarachnoid hemorrhage (SAH) in rats.Brain Res. 2003 Aug 15;981(1-2):58-69. doi: 10.1016/s0006-8993(03)02920-2. Brain Res. 2003. PMID: 12885426
-
Blocking VEGF by Bevacizumab Attenuates VEGF-Induced Vasospasm After Experimental Subarachnoid Hemorrhage in Rabbits.World Neurosurg. 2020 Jul;139:e136-e143. doi: 10.1016/j.wneu.2020.03.151. Epub 2020 Apr 3. World Neurosurg. 2020. PMID: 32251821
-
Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.J Neurosurg. 2017 Aug;127(2):291-301. doi: 10.3171/2016.5.JNS152900. Epub 2016 Oct 7. J Neurosurg. 2017. PMID: 27715439
-
Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm.Neurosurgery. 1998 Dec;43(6):1409-17; discussion 1417-8. Neurosurgery. 1998. PMID: 9848855 Review.
Cited by
-
HIF-1α Mediates Isoflurane-Induced Vascular Protection in Subarachnoid Hemorrhage.Ann Clin Transl Neurol. 2015 Apr;2(4):325-37. doi: 10.1002/acn3.170. Epub 2015 Feb 21. Ann Clin Transl Neurol. 2015. PMID: 25909079 Free PMC article.
-
Evaluation of Vascular Endothelial Growth Factor A and Selected Parameters of Coagulation and Fibrinolysis in a Group of Patients with Subarachnoid Haemorrhage.Biomed Res Int. 2019 Jul 8;2019:8759231. doi: 10.1155/2019/8759231. eCollection 2019. Biomed Res Int. 2019. PMID: 31360727 Free PMC article. Clinical Trial.
References
-
- Haley EC, Jr., Kassell NF, Alves WM, et al. Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. Journal of Neurosurgery. 1995;82(5):786–790. - PubMed
-
- Haley EC, Jr., Kassell NF, Apperson-Hansen C, Maile MH, Alves WM. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. Journal of Neurosurgery. 1997;86(3):467–474. - PubMed
-
- Kassell NF, Torner JC, Haley EC, Jr., Jane JA, Adams HP, Kongable GL. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: overall management results. Journal of Neurosurgery. 1990;73(1):18–36. - PubMed
-
- Lanzino G, Kassell NF. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America. Journal of Neurosurgery. 1999;90(6):1018–1024. - PubMed
-
- Lanzino G, Kassell NF, Dorsch NWC, et al. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa. Journal of Neurosurgery. 1999;90(6):1011–1017. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources